Table 2.
Univariate analysis
| mRS 0–2 |
sICH |
mRS 6 |
||||
|---|---|---|---|---|---|---|
| yes (n = 48) | no (n = 51) | yes (n = 12) | no (n = 87) | yes (n = 19) | no (n = 80) | |
| Age, years | 64.8±9.2 | 70.2±9.1* | 67.4±9.7 | 68.4±7.7 | 71.3±8.5 | 66.6±9.5* |
| Males | 39 (81.2) | 38 (74.5) | 9 (75.0) | 68 (78.1) | 14 (73.7) | 63 (78.7) |
| HBP | 29 (60.4) | 35 (68.6) | 8 (66.7) | 56 (64.3) | 15 (78.9) | 49 (61.2) |
| Diabetes | 8 (16.6) | 18 (35.3)* | 5 (41.7) | 21 (24.1) | 6 (31.6) | 20 (25.0) |
| Dyslipidemia | 28 (58.3) | 30 (58.8) | 8 (66.7) | 50 (57.5) | 9 (47.4) | 49 (61.2) |
| Smoking | 27 (56.2) | 29 (55.8) | 8 (66.7) | 48 (55.1) | 12 (63.2) | 44 (55.0) |
| Previous CVA/TIA | 7 (14.6) | 10 (19.6) | 1 (8.3) | 16 (18.4) | 3 (15.8) | 14 (17.5) |
| Coronary heart disease | 4 (8.3) | 9 (17.6) | 1 (8.3) | 12 (13.8) | 6 (31.6) | 7 (8.7)* |
| Antithrombotic treatment | 21 (43.7) | 21 (41.2) | 6 (50.0) | 36 (41.3) | 12 (63.2) | 30 (37.5)* |
| NIHSS | 15 (13−18) | 18 (13−21)* | 15 (13–15) | 16.5 (11–21) | 21 (14−23) | 15 (13−19) |
| ASPECTS | 8 (8–9) | 9 (8–9) | 8 (8–9) | 8 (7–9) | 8 (7–9) | 9 (8–9) |
| i.v. fibrinolysis | 11 (22.9) | 10 (19.6) | 3 (25.0) | 18 (20.7) | 3 (15.8) | 18 (22.5) |
| Time from symptom onset to arterial puncture, min | 186.5±69.1 | 230.9±101.61* | 270.1±116.3 | 197.6±79.8* | 218.7±99.8 | 204.6±85.9 |
| Time from symptom onset to recanalization, min | 242.1±80.3 | 291.6±93.8* | 340.9±106.2 | 250.1±79.4* | 302.1±82.9 | 255.5±89.1* |
| Complete recanalization | 48 (100) | 39 (76.5)* | 10 (83.3) | 77 (88.5) | 14 (73.7) | 73 (91.2)* |
| Blood glucose, mg/dL | 118.8±35.4 | 148.9±65.6* | 130.1±50.8 | 165.6±74.6* | 151.8±66.3 | 130.2±51.5 |
| Systolic BP, mm Hg | 153.7±25.1 | 151.3±33.6 | 152.9±30.8 | 148.9±22.7 | 156.2±30.4 | 151.5±29.8 |
| Diastolic BP, mm Hg | 84.4±15.8 | 81.7±15.1 | 83.01±22.1 | 82.5±14.8 | 88.1±36.3 | 81.7±15.6 |
Values are presented as means ± SD, medians (IQR), or numbers (%). HBP, high blood pressure; TIA, transient ischemic attack; BP, blood pressure.
*
p < 0.05.